| Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2 … JPH Machiels, RT Reilly, LA Emens, AM Ercolini, RY Lei, D Weintraub, ... Cancer research 61 (9), 3689-3697, 2001 | 552 | 2001 |
| Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2 … JPH Machiels, RT Reilly, LA Emens, AM Ercolini, RY Lei, D Weintraub, ... Cancer research 61 (9), 3689-3697, 2001 | 552 | 2001 |
| Loss of FHIT Expression in Cervical Carcinoma Cell Lines and Primary Tumors DL Greenspan, DC Connolly, R Wu, RY Lei, JTC Vogelstein, YT Kim, ... Cancer research 57 (21), 4692-4698, 1997 | 222 | 1997 |
| The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors RT Reilly, JPH Machiels, LA Emens, AM Ercolini, FI Okoye, RY Lei, ... Cancer Research 61 (3), 880-883, 2001 | 204 | 2001 |
| Four-year clinical update from a prospective trial of accelerated partial breast intensity-modulated radiotherapy (APBIMRT) RY Lei, CE Leonard, KT Howell, PL Henkenberns, TK Johnson, TL Hobart, ... Breast cancer research and treatment 140, 119-133, 2013 | 60 | 2013 |
| The impact of genomic testing on the recommendation for radiation therapy in patients with ductal carcinoma in situ: A prospective clinical utility assessment of the 12‐gene … M Alvarado, DL Carter, JM Guenther, J Hagans, RY Lei, CE Leonard, ... Journal of surgical oncology 111 (8), 935-940, 2015 | 49 | 2015 |
| Clinical Utility of the 12-Gene Ductal Carcinoma In Situ (DCIS) Score Assay: Impact on Treatment (tx) Recommendations CE Leonard, RY Lei, MD Alvarado, J Guenther, JE Hagans, JB Manders, ... International Journal of Radiation Oncology, Biology, Physics 90 (1), S223-S224, 2014 | 15 | 2014 |
| Cyclophosphamide, doxorubicin and paclitaxel enhance the antitumor immune response of GM-CSF-secreting whole cell vaccines in HER-2-neu tolerized mice JP Machiels, RT Reilly, LA Emens, AM Ercolini, RY Lei, D Weintraub, ... Cancer Res 61 (9), 3689-3697, 2001 | 14 | 2001 |
| A comparison of predicted ipsilateral tumor recurrence risks in patients with ductal carcinoma in situ of the breast after breast-conserving surgery by breast radiation … RY Lei, DL Carter, AG Antell, MA Nowels, SP Tole, JP Bennett, M Turner, ... Advances in Radiation Oncology 6 (2), 100607, 2021 | 13 | 2021 |
| External beam accelerated partial breast irradiation yields favorable outcomes in patients with prior breast augmentation RY Lei, CE Leonard, KT Howell, PL Henkenberns, TK Johnson, TL Hobart, ... Frontiers in Oncology 4, 154, 2014 | 13 | 2014 |
| A prospective Phase III trial evaluating patient self‐reported pain and cosmesis in accelerated partial breast irradiation utilizing 3‐D versus intensity‐modulated radiotherapy CE Leonard, Y Wang, L Asmar, RY Lei, KT Howell, PL Henkenberns, ... Cancer Medicine 10 (20), 7089-7100, 2021 | 5 | 2021 |
| A comparison of models (physician, the Van Nuys prognostic index, the Memorial-Sloan-Kettering Cancer Center DCIS nomogram) to predict ipsilateral breast events in patients … C Leonard, R Lei, A Antell, M Nowels, S Fryman, K Howell, C Dennis CANCER RESEARCH 77, 2017 | 2 | 2017 |
| Clinical utility of the 12-gene DCIS score assay: Impact on treatment (Tx) recommendations. M Alvarado, D Carter, JM Guenther, J Hagans, R Lei, CE Leonard, ... Journal of Clinical Oncology 32 (15_suppl), 11050-11050, 2014 | 2 | 2014 |
| A prospective investigation of definitive targeted therapy for solid malignancies with oligometastases RY Lei, SP Fryman, AL White, WE Daniel, AG Antell, M Patel, DL Carter International Journal of Radiation Oncology, Biology, Physics 84 (3), S632, 2012 | 2 | 2012 |
| Patterns of surgical and radiation treatment for early-stage breast cancer in the state of Colorado RY Lei, CE Leonard, MA Nowels, V Katamaneni, DL Carter International Journal of Radiation Oncology, Biology, Physics 93 (3), E371, 2015 | 1 | 2015 |
| Disease control efficacy of ductal carcinoma in situ (DCIS) treated with accelerated partial breast irradiation (APBI) RY Lei, CE Leonard, KT Howell, RM LaPorte, PL Henkenberns, ... International Journal of Radiation Oncology, Biology, Physics 87 (2), S196, 2013 | 1 | 2013 |
| Four-year clinical update from a prospective trial of accelerated partial breast intensity modulated radiotherapy RY Lei, CE Leonard, KT Howell, PL Henkenberns, MJ Tallhamer, ... International Journal of Radiation Oncology, Biology, Physics 81 (2), S215, 2011 | 1 | 2011 |
| Abstract P1-11-02: A comparison of models (physician, the Van Nuys prognostic index, the Memorial-Sloan-Kettering Cancer Center DCIS nomogram) to predict ipsilateral breast … C Leonard, R Lei, A Antell, M Nowels, S Fryman, K Howell, C Dennis Cancer Research 77 (4_Supplement), P1-11-02-P1-11-02, 2017 | | 2017 |
| Comparison of Risk of Ipsilateral Breast Event After Lumpectomy for Ductal Carcinoma In Situ, As Estimated by Breast Radiation Oncologists, Van Nuys Prognostic Index, Memorial … RY Lei, DL Carter, AG Antell, MA Nowels, SP Fryman, E Janotta, ... International Journal of Radiation Oncology, Biology, Physics 93 (3), E45, 2015 | | 2015 |
| Francesca I. Okoye, and Elizabeth M. Jaffee² The Johns Hopkins University School of Medicine, Department of Oncology, Graduate Program in Immunology, Baltimore, Maryland 21231 JPH Machiels, RT Reilly, LA Emens, AM Ercolini, RY Lei, D Weintraub Cancer Research 61, 3689-3697, 2001 | | 2001 |
Joshua T. VogelsteinDept of Biomedical Engineering, Johns Hopkins UniversityVerified email at jhu.edu
